Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy
预测接受免疫检查点抑制剂治疗的非小细胞肺癌患者的生存期：免疫相关不良事件和既往酪氨酸激酶抑制剂治疗的影响和时间
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1064169
Sayer, Michael R; Mambetsariev, Isa; Lu, Kun-Han; Wong, Chi Wah; Duche, Ashley; Beuttler, Richard; Fricke, Jeremy; Pharoan, Rebecca; Arvanitis, Leonidas; Eftekhari, Zahra; Amini, Arya; Koczywas, Marianna; Massarelli, Erminia; Roosan, Moom Rahman; Salgia, Ravi
